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Vertebrate Parasitization
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Howard Hughes Medical Institute, Department of Medicine and Department of Microbiology/Immunology, 
University of California San Francisco, San Francisco, CA 94143
 
Abstract
 
The 
 
Leishmania major
 
 LACK antigen is a key target of the immune response in susceptible
BALB/c mice and remains a viable vaccine candidate for human leishmaniasis. We describe the
genomic organization of the four 
 
lack
 
 genes in the 
 
L. major
 
 diploid genome together with results
of selected 
 
lack
 
 gene targeting. Parasites containing a single 
 
lack
 
 gene in either the upstream or
downstream locus grew comparably to wild-type promastigotes in vitro, but failed to parasitize
BALB/c mice efficiently, even in a T cell–deficient environment. The replication of single
copy 
 
lack
 
 mutants as amastigotes was attenuated in macrophages in vitro, and parasites failed to
increase in numbers in immunodeficient mice, despite their persistence over months. Comple-
mentation with an additional 
 
lack
 
 copy was sufficient to induce robust lesion development,
which also occurred using parasites with two 
 
lack
 
 genes. Conversely, attempts to generate 
 
lack
 
-
null parasites failed, suggesting that LACK is required for parasite viability. These data suggest
that LACK is critical for effective mammalian parasitization and thus represents a potential drug
target for leishmaniasis.
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Introduction
 
Leishmania major
 
 is a protozoan pathogen transmitted by
phlebotomine sandflies and thrives in phagolysosomal com-
partments within macrophages of vertebrate hosts. The
 
L. major
 
 LACK (Leishmania homologue of mammalian
RACKs, the receptors for activated C kinase) antigen was
identified by screening a parasite expression library as the
antigen recognized by a protective murine CD4 T cell
clone (1). Additional studies suggested that experimental
infection of susceptible BALB/c mice with 
 
L. major
 
 nucleated
a dominant population of LACK-specific V
 

 
4
 
 
 
Th2 cells
necessary for progressive infection (2, 3). Antagonism of
the LACK-specific CD4 T cell response by altered peptide
ligands (4) or deletion of LACK-reactive T cells by expression
of a LACK transgene in the mouse thymus (5) resulted in a
Th1 response and control of disease in BALB/c mice.
The immunologic response to LACK has been exquisitely
characterized in BALB/c mice. Within the first 3–4 d after
inoculation of parasites, a small number of naive CD4 T
cells with appropriate specificity for a dominant I-A
 
d
 
LACK peptide expand over 120-fold and begin to express
IL-4 transcripts that characterize Th2 immune responses
(6). Intriguingly, the preinfection repertoire and the postin-
fection expansion and acquisition of IL-4 transcripts among
LACK-reactive CD4 T cells were not different in comparing
susceptible and resistant inbred mouse strains. The factors
that underlie the immunodominance of the LACK epitope
in the I-A
 
d 
 
Th response remain unknown, although these
are unlikely to reflect the overall abundance of the LACK
protein because other 
 
L. major
 
 surface proteins such as
GP63 are more highly expressed (4, 7). Whether the focus
of the immune response on LACK is detrimental to the
parasite remains unknown, but immunization with LACK
is highly efficacious in protection against subsequent infection
(8–10).
 
L. major
 
 LACK and its mammalian homologue,
RACK1, belong to the WD repeat protein family. These
macromolecules are evolutionarily conserved tryptophan
aspartate motif proteins and have diverse but critical functions
in eukaryotes, including signal transduction, RNA processing,
and cell cycle control (11). In most cases, however, little is
known about their molecular functions. The crystal structure
has been best determined for one eukaryote WD repeat
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protein, the G
 
 
 
subunit of transducin, a heterotrimeric G
protein in the visual signaling pathway of rod cells (12).
The G
 
 
 
subunit adopts a flat, seven-bladed, propeller-like
structure, suggesting that WD repeat proteins may function
by providing a stable interaction surface upon which to
scaffold a variety of multiprotein signaling complexes (13).
The RACK1 protein was identified (14) based on its ability
to bind activated protein kinase C
 
 
 
(
 

 
IIPKC) and modu-
late its subcellular localization (15, 16). Consistent with a
more generalized role as an adaptor molecule, RACK1 has
subsequently been found to interact with additional pro-
teins, such as dynamin-1 and Src, and protein complexes
(17–21).
Few studies have addressed the physiologic role of the
LACK family of proteins in kinetoplastids. Trypanosomes
up-regulate the homologous WD repeat protein, desig-
nated TRACK, in parasites undergoing apoptosis and in
terminally differentiated bloodstream forms (22). In 
 
Leish-
mania infantum
 
, LACK was localized near the kinetoplast,
and peptide display suggested an interaction with sequences
from proteins involved in DNA replication and RNA syn-
thesis (23). In contrast, the homologue in 
 
Crithidia fascicu-
lata
 
, designated CACK, localized to the plasma membrane,
consistent with a role in protein kinase C (PKC) localiza-
tion similar to RACK1 (24). It remains possible that kine-
toplastid LACK homologues interfere with their mamma-
lian counterparts during parasitization. RACK1 has been
implicated in negative regulation of microbicidal oxygen
radical generation in HL60 cells (25) and the Epstein Barr
virus RACK-binding protein, ZEBRA, was implicated in
interfering with PKC-mediated phagocytosis and inflam-
matory cytokine production by infected macrophages (26).
Macrophages infected with 
 
L. major
 
 demonstrated a delay
in the dissociation of activated PKC
 
 
 
that correlated with
down-regulation of TNF
 
 
 
expression (27). Clearly, further
genetic and biochemical studies are required to understand
the biology of the LACK family proteins in kinetoplastids.
We used gene-targeting strategies to create LACK-defi-
cient strains of 
 
L. major
 
 to determine the role of LACK in
the parasite life cycle. The 
 
lack
 
 genes of 
 
L. major
 
 consist of a
tandem duplicate family. 
 
lack
 
-null parasites could not be
generated, suggesting an essential role for LACK in viability.
Although haploid parasites containing a single allele with
two genes were indistinguishable from wild-type 
 
L. major
 
,
parasites containing single copy 
 
lack1
 
 or 
 
lack2
 
 genes were
highly attenuated when used to infect susceptible BALB/c
mice. Indeed, single copy mutants were unable to produc-
tively infect T- or T- and B cell–deficient mice, suggesting
a necessary role for LACK in vertebrate parasitization.
 
Materials and Methods
 
Parasites. L. major
 
 strain WHOM/IR/-/173 was cultured in
medium 199 (M199; Sigma-Aldrich) supplemented with 10%
heat-inactivated FCS (Atlanta Biologicals) as previously described
(28). For growth assays, designated parasites from stationary phase
cultures were diluted 1 in 50 and 1 in 15 in fresh medium and in-
cubated at 27 and 37
 

 
C, respectively. Parasites were enumerated
 
daily by counting in a hemocytometer after fixation in 0.4%
formaldehyde in PBS. Metacyclogenesis of designated 
 
L. major
 
mutants was assessed by staining parasites from 2- and 8-d cul-
tures with 12 
 

 
g/ml Alexa 488 conjugated to peanut agglutinin
(Ax-PNA; Molecular Probes) in PBS for 30 min at 4
 

 
C. Parasites
were washed and analyzed by flow cytometry (FACSCalibur™;
Becton Dickinson).
 
Constructs for lack Gene Targeting and Complementation.
 
A se-
ries of targeting constructs was assembled in plasmid pGEM-
9Zf(
 

 
) (Promega) using regions flanking the tandem 
 
lack
 
 genes,
designated 
 
lack1
 
 and 
 
lack2
 
, coupled to various drug selection cas-
settes (see Fig. 1, A and B). The entire 
 
lack1
 
/
 
lack2
 
 locus, includ-
ing the 3.3-kb intergenic region, was targeted using the 1.3-kb
sequence immediately upstream of the 
 
lack1
 
 start codon, the hy-
gromycin B phosphotransferase coding region (
 
hyg
 
) ligated to
the 3
 
 
 
UTR of the 
 
L. major
 
 
 
dhfr-ts
 
 gene (28, 29), and a 0.9-kb
fragment beginning 190 bp 3
 
 
 
of the 
 
lack2
 
 stop codon. The final
targeting vector, designated pLHDL, was verified by direct se-
quencing, as were each of the subsequent targeting constructs
(see Fig. 1 B). A comparable targeting construct, designated
pLSDL, was identical to pLHDL except that the 
 
hyg
 
 coding re-
gion was replaced by the 0.5-kb region coding for the strepto-
thrycin acetyltransferase gene (
 
sat
 
) that confers nourseothricin
resistance (28, 29).
The 
 
lack1
 
 gene was targeted using vector pL1SDL1, contain-
ing a 
 
sat
 
 drug selection cassette flanked by 1.3 kb upstream 
 
lack1
 
sequence and the 3.3-kb intergenic sequence. The 
 
lack2
 
 gene was
targeted using vector pL2PDL2, containing a puromycin acetyl-
transferase (
 
pac
 
) selection cassette inserted downstream of a 1.5-kb
sequence immediately upstream of the 
 
lack2
 
 start codon and up-
stream of a 0.6-kb sequence beginning 202 bp downstream of the
 
lack2
 
 stop codon (see Fig. 1, A and B).
Genetic complementation of LACK-deficient parasites was
performed by inserting an XhoI-tagged 
 
lack
 
 wild-type coding re-
gion between the puromycin selection cassette and the 0.6-kb
 
lack2
 
 3
 
 
 
flanking sequence in pL2PDL2. The resulting targeting
vector was designated pL2PD-LK
 
	
 
-L2 (see Fig. 1 B).
To determine the cellular location of LACK in 
 
L. major
 
, the
green fluorescent protein (GFP) coding sequence (30) was fused
using PCR to the 5
 
 
 
end of the 
 
lack
 
 gene and inserted down-
stream of the DHFR sequence in construct pL1SDGLKL1 (see
Fig. 1 B, 5). A control construct, pL1SDGL1, was made identical
to pL1SDGLK1 except the 
 
gfp
 
 coding sequence was used alone in
place of the fused 
 
gfp-lack
 
 sequence (see Fig. 1 B, 6).
 
Transfection and Selection of lack-targeted L. major.
 
The first 
 
lack
 
allele was targeted by electroporation of 20 
 

 
g Qiaex II–purified
insert (QIAGEN) from pLHDL double digested with NotI/XbaI
(see Fig. 1 B). Deficient clones, designated 
 
lack
 

 
/
 

 
, were
selected after plating on semisolid M199 containing 32 
 

 
g/ml
hygromycin B as previously described (28, 29). Deletion of the
remaining 
 
lack
 
 allele was attempted after electroporation of 20 
 

 
g
purified insert from pLSDL and selection on plates containing 60
 

 
g/ml nourseothricin followed by culture in liquid media con-
taining 30 
 

 
g/ml nourseothricin plus 16 
 

 
g/ml hygromycin B,
as previously described (29).
To target the individual 
 
lack1
 
 and 
 
lack2
 
 genes, 
 
lack
 

 
/
 

 
parasites were transfected with 20 
 

 
g Qiaex II–purified insert ex-
cised from pL1SDL1 and pL2PDL2, respectively. Transfectants
were selected in the presence of nourseothricin (60 
 

 
g/ml semi-
solid media and 30 
 

 
g/ml liquid media) and puromycin (22 
 

 
g/
ml semisolid media and 11 
 

 
g/ml liquid media), respectively. Ef-
fective complementation of 
 
L. major
 
 
 
lack
 

 
/
 
 
 
parasites was
achieved by transfection of 
 
L. major
 
 
 
lack
 

 
/
 
 
 
with 20 
 

 
g pu-
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rified targeting fragment L2PD-LK
 
	
 
-L2 containing the XhoI-
modified LACK2 construct.
For analysis of the cellular localization of LACK, 
 
lack
 

 
/
 

 
parasites were transfected with 30 
 

 
g pL1SDGLKL1 or
pL1SDGL1 and selected on plates and in liquid media as de-
scribed for the pLSDL insert.
 
Southern Blotting to Confirm Gene Targeting.
 
Genomic DNAs
were isolated from wild-type and 
 
L. major
 
 transfectant clones as
previously described (31), digested with the designated restriction
enzymes and size fractionated by agarose gel electrophoresis. The
nucleic acids were blotted onto nylon membranes (Hybond N
 

 
;
Amersham Biosciences) and hybridized using Rapid-Hyb (Amer-
sham Biosciences) with DNA fragments 
 
g
 
 or 
 
h corresponding to
the lack1 coding region and the most 3 region of the lack allele,
respectively (see Fig. 1 A), according to the manufacturer’s in-
structions. Blots were washed at 65C with 2X SSC-0.2X SSC/
0.5% SDS.
Western Blotting Analysis. Lysates from 2 
 106 or 2 
 107
parasites per lane were run on 4–20% gradient SDS-PAGE
gels (Invitrogen) and blotted onto Hybond-C (Amersham Bio-
sciences) according to the manufacturer’s instructions. After
overnight blocking in 5% milk powder (32) in TBS with 0.05%
Tween 20 (TBS/T) at 4C, blots were incubated with 1:4,000
rabbit anti–LACK antiserum (1) for 1 h at room temperature. Af-
ter washing in TBS/T, blots were incubated with 1:3,000 goat
anti–rabbit-Ig conjugated with horseradish peroxidase for 30
min. The blots were washed and developed using ECL chemilu-
minescence reagent (Amersham Biosciences) according to the
manufacturer’s instructions. Loading was verified by stripping the
blots (62.5 mM Tris HCl, pH 6.8, 2% SDS, and 100 mM -mer-
captoethanol at 65C for 30 min) and reprobing with polyclonal
antisera (1:300) against the conserved 40S ribosomal protein, S6
(Santa Cruz Biotechnology, Inc.).
Fluorescence Microscopy. Parasites transfected with pL1SDGLKL1
and pL1SDGL1 were diluted 1/10 in PBS/0.02% formaldehyde.
Images of fluorescent parasites were acquired using a Nikon
ECLIPSE E800 microscope (Nikon) in the FITC channel and
viewed at 
1,000.
Figure 1. Targeting the L. major
lack genes. (A) Physical map
showing organization of the L.
major lack genes. Restriction
enzyme cut sites are indicated: B,
BamHI; H, HindIII; K, KpnI; N,
NsiI; No, NotI; S, StuI; Sp,
SphI; Spe, SpeI; X, XbaI. Gray
boxes denote lack1 and lack2
open reading frames. Fragments g
and h (triple lines) were used as
probes for Southern hybridization
analysis. Fragments a–f (heavy
lines) were used to make targeting
constructs (B, 1–4) and episomal
GFP-LACK and GFP expression
constructs (B, 5 and 6). (B) Car-
toon of the targeting constructs
used for generating organisms
used in these studies (refer to
Materials and Methods). (C)
Southern hybridization of L. major
transfectant genomic DNAs. Ge-
nomic DNAs (10 g/lane) from
untransfected L. major (lane 1) or
LHDL transfectants (L. major
lack/; lane 2) were di-
gested with KpnI. Genomic DNAs
from L. major lack/ (lane
3), L. major lack/ trans-
fected with L2PDL2 (L. major
lack/; lane 4), and L. major
lack/ transfected with
L1SDL1 (L. major lack/;
lane 5) were double digested
with StuI and BamHI. DNAs
from L. major lack/ trans-
fected with L2PD-LK	-L2 (L.
major lack	/) were digested
with StuI (lane 6). Blots were
either hybridized with fragment
h (lanes 1 and 2) or fragment g
(lanes 3–6).
LACK-targeted Leishmania1692
Mice and Infections. BALB/c and BALB/c 
 RAG-2-defi-
cient mice were purchased from The Jackson Laboratory. TCR-
C–deficient mice were crossed 10 generations to BALB/c (33,
34). Animals were maintained in the University of California San
Francisco specific pathogen-free barrier facility according to insti-
tutional protocols.
Cohorts of designated mice were inoculated subcutaneously in
the left hind footpad with 2 
 106 metacyclic promastigotes, pre-
pared as previously described (4). The relatively high inoculum
was selected as a rigorous test of virulence based on preliminary
experiments determining the capacity of resistant C57BL/6 and
IL-4R–deficient BALB/c mice to control these inocula (un-
published data). Lesions were measured weekly using a vernier
caliper. At the end of the infection, popliteal lymph nodes were
collected from infected mice, dispersed into 5 ml M199 with 10%
FCS, and diluted into microtiter wells in duplicate. After 7 d of
culture at 27C, parasite numbers were quantitated by micro-
scopic determination of the last well containing viable organisms.
Analysis of the LACK-specific CD4 T Cell Response. BALB/c
mice were inoculated in the footpad with 2 
 106 designated
metacyclic parasites. After 96 h, the draining popliteal lymph
nodes were harvested and the CD4 T cells were incubated with
I-Ad/LACK peptide MHC class II tetramers as previously de-
scribed (6). Tetramer T cells were analyzed using a MoFlo® high
speed cell sorter (DakoCytomation) and FlowJo® software (Tree
Star) as previously described (6).
Macrophage Infections. Bone marrow–derived macrophages
from BALB/c mice were cultured on glass chamber slides (Lab-
Tek; Nunc) as previously described (35). Promastigotes, at a ratio
of approximately three per macrophage, were coincubated with
the macrophages for 16 h at 35C and washed in warm PBS to
remove extracellular organisms. Monolayers were stained imme-
diately after 96 h of incubation at 35C using Diff-Quik (DADE
Behring) and the number of amastigotes per cell was determined
by light microscopy.
Results
The lack Gene Locus in L. major. The organization of
the lack genes was determined by Southern blot analysis us-
ing the lack coding region as a hybridization probe. The
genes are arrayed in two tandemly linked, head to tail cop-
ies on a 10-kb StuI fragment on parasite chromosome 29
(Fig. 1 A and unpublished data). The cloned genomic frag-
ment was sequenced and the two predicted lack protein-
coding regions were identical. Comparisons of the 5 and
3 noncoding sequences showed divergence of the two
genes 244 nucleotides upstream of the start codons and 190
nucleotides downstream of the stop codons. The 5 mini-
exon consensus capping sequence (36) is spliced onto the
LACK mRNA at an AG dinucleotide 33 bp upstream of
the start codon. Northern blots using gene-specific probes
generated from the unique flanking regions showed the 5
and 3 lack genes, designated lack1 and lack2, encode 1.8
and 1.5 kb mRNAs, respectively (unpublished data).
Generation of Double and Single Copy lack Parasites.
Gene targeting constructs were generated from the cloned
and sequenced 5 and 3 regions flanking the lack open read-
ing frames as described in Materials and Methods (Fig. 1 B).
After selection in drug-containing media, parasites deficient
in one lack allele, designated lack/, were expanded
and characterized by Southern blotting. Consistent with de-
letion of one of the lack alleles, a 13-kb KpnI fragment con-
taining both lack genes in the wild-type parasites was re-
duced to a 10-kb fragment in lack/ parasites when
hybridized with probe h (Fig. 1 C, lanes 1 and 2).
Targeting the remaining two lack genes in lack/
parasites was attempted using the same targeting construct
except that the hygromycin B phosphotransferase selection
cassette was replaced with the streptothrycin acetyltrans-
ferase cassette, thus allowing selection in nourseothricin
(refer to Materials and Methods). Repeated transfections
resulted in failure to grow parasites in double drug selection
media, suggesting that lack and/or its associated flanking re-
gions are necessary for promastigote viability. This was not
due to failure of selection using the nourseothricin cassette,
as lack/ parasites could be readily generated using
Figure 2. LACK protein deter-
minations and subcellular local-
ization. (A) LACK protein expres-
sion in lack-targeted L. major
lines. Lysates from 2 
 107 lack-
targeted L. major promastigotes
were loaded, blotted, and probed
with rabbit polyclonal anti-
serum raised against recombinant
LACK protein (top). The blot
was stripped and reprobed with
goat polyclonal antiserum against
eukaryotic 40S ribosomal protein
S6 (bottom). Size markers (kD)
are indicated. (B) Localization
of GFP-LACK in L. major
promastigotes. Stationary
phase pL1SDGLKL1 transfec-
tants were diluted 1 in 10 in
PBS/0.02% formaldehyde. The
parasites were viewed at 
1,000
with fluorescent excitation at
460–500 nm. Promastigote nu-
cleus (N) and flagellum (Fl) are
marked. (C) Localization of GFP
in L. major promastigotes. Station-
ary phase pL1SDGL1 transfectants
were treated and analyzed as de-
scribed in B. (D) GFP-LACK
protein expression in L. major
lack/ transfectants. Para-
sites expressing GFP-LACK or
GFP are indicated. Lanes 1 and
2, 2 
 107 organisms; lanes 3 and
4, 2 
 106 organisms. Location
of endogenous LACK and GFP-
LACK are indicated by large and
small arrows, respectively.
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this targeting construct to delete one of the lack alleles (un-
published data).
Single copy lack parasites were generated by targeting the
remaining lack1 or lack2 genes in lack/ organisms,
using further selection in nourseothricin or puromycin, re-
spectively (refer to Materials and Methods; Fig. 1 B). South-
ern blotting using the lack coding region as a hybridization
probe showed loss of the 3-kb StuI/BamHI (lack1) and 7-kb
StuI/BamHI (lack2) fragments in the respective lines, thus
confirming generation of mutants with a single haploid copy
of either lack1/ or lack2/ (Fig. 1 C, lanes 4
and 5, respectively). Attempts to delete the remaining copy
of lack1 in lack/ parasites were unsuccessful, consis-
tent with an essential role for the lack locus in L. major.
To effectively determine the effects of complementation
with the lack2 coding region, the lack2 gene in lack/
 parasites was replaced in cis using a lack2 mutant (	;
Fig. 1 B, 4) containing an XhoI-tagged lack coding region
to allow discrimination from endogenous lack. Southern
blotting of the resulting parasite’s DNA after StuI digestion
revealed lack-hybridizing fragments of 4.9 and 5.4 kb, rep-
resenting the endogenous lack1 gene and the reconstituted
XhoI-marked lack2 copy, respectively (Fig. 1 C, lane 6).
The reconstituted double copy mutants were designated
lack	/–.
Levels of LACK protein were assessed in the various lack
mutants using Western blotting with anti-LACK antise-
rum. In multiple experiments, LACK protein levels were
comparable between wild-type and lack/ L. major
(unpublished data). After adjusting for differences in load-
ing based on the intensity of eukaryote ribosomal protein
S6 expression (Fig. 2 A, bottom), densitometric analysis of
the bands showed the level of LACK protein was approxi-
mately threefold reduced in L. major lack/ and
lack	/–, with relative band densities of 1.0 and 0.8, re-
spectively, as compared with L. major lack/, which
showed a relative band density of 2.7 (Fig. 2 A, top).
Localization of LACK by immunofluorescence micros-
copy of pL1SDGLKL1 transfectants indicated that the
GFP-LACK fusion protein localized to the cytosol of the
promastigote cell body but was excluded from organelles
such as the nucleus and other vacuolar structures and was
also absent from the flagellum (Fig. 2 B). In contrast, GFP
from pL1SDGL1 transfectants, although excluded from
certain vacuolar structures, was localized throughout the
cytosol, nucleus, and flagellum (Fig. 2 C). Comparable
fluorescence patterns were observed in both strongly and
weakly fluorescent transfectants, containing high and low
copy numbers of the construct, respectively, suggesting that
this distribution was not an effect of LACK overexpression.
Further, and consistent with the relatively low level expres-
sion of the GFP-LACK fusion protein, Western blotting of
lysates from pL1SDGLKL1 transfectants using anti-LACK
antiserum revealed a 63-kD protein that was substantially
less abundant than the endogenous LACK, even in
lack/ organisms that contained a single allele (Fig. 2
D). Immunolocalization of LACK in promastigotes using
anti-LACK antiserum showed a pattern of staining similar
to the fluorescence observed in the pL1SDGLKL1 transfec-
tants (unpublished data).
Attenuation of Virulence in Mice Using Single Copy lack Mu-
tant Parasites. An epitope from the LACK protein of L.
major displayed in I-Ad constitutes a crucial recognition ele-
ment for susceptibility-promoting Th2 cells in BALB/c
mice (4). To ascertain whether moderation of LACK ex-
pression would affect the capacity to cause disease, the var-
ious mutant organisms were used to infect BALB/c mice.
We first established that each of the parasites grew compa-
rably as promastigotes at 27C in vitro and that metacyclo-
genesis remained unimpaired. Growth of wild-type para-
sites in vitro and in the sandfly in vivo is associated with
differentiation of promastigotes from noninfectious, rapidly
dividing forms, to highly infectious, nondividing forms,
termed metacyclics. Modifications of parasite surface carbo-
hydrate moieties that accompany this transition allow
metacyclic parasites to be distinguished from noninfectious
stages based on their reduced ability to bind the lectin pea-
nut agglutinin (PNA; reference 37). Parasites were col-
lected during rapid growth on day 2 and during stationary
phase on day 8, and assessed for PNA binding using flow
cytometry. Both the percentages of organisms binding
PNA and the intensity of staining were similar among all
lack-targeted promastigotes when compared with wild-type
L. major (Fig. 3 and unpublished data). These data suggest
that metacyclogenesis is not impaired in the various LACK
mutant promastigotes.
Cohorts of BALB/c mice were infected in the footpads
with selected, metacyclic parasites, and the course of disease
Figure 3. Analysis of metacyclogenesis in lack-targeted L. major. Pro-
mastigotes from 2- or 8-d cultures were stained with Alexa 488 conjugated to
PNA and analyzed by flow cytometry. Dashed line, L. major lack/;
solid line, L. major lack/; dotted line, unstained control.
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was followed over time. In multiple experiments, double
copy lack/ parasites produced lesions in mice that
were indistinguishable from wild-type L. major that had been
comparably passaged (unpublished data). However, in com-
parison to lack/ metacyclics, lack/ and
lack/ metacyclic promastigotes showed significantly
impaired lesion development (Fig. 4 A) and diminished re-
covery of viable parasites from infected mice (Fig. 4 E and
unpublished data). Replacement of the endogenous lack2
coding region of lack/ parasites with the XhoI-tagged
lack2 coding region (	) preserved the capacity to produce
lesions and recover parasites in recipient mice, suggesting that
virulence had been attenuated by LACK deficiency (Fig. 4, D
and E). Thus, despite comparable growth in vitro as promas-
tigotes, the single copy lack parasites demonstrated marked at-
tenuation of growth in vivo in susceptible mice.
Because initial activation of the LACK-reactive CD4 T
cell response has been associated with susceptibility of
Figure 4. Lesion development and parasite burden after
inoculation of lack-targeted L. major. Wild-type BALB/c
mice (A and D), TCR C/ BALB/c mice (B), or
RAG-2–deficient BALB/c mice (C) were infected in the
hind footpad with 2 
 106 lack-targeted L. major using the
indicated strains (four to five mice per data point). Lesion
development in the left footpad was monitored using calipers.
Parasites recovered from the draining popliteal lymph
nodes of wild-type BALB/c mice infected for 125 d (E) or
RAG-2–deficient BALB/c mice infected for 80 d (F) with
the indicated lack-targeted parasites. Bars indicate averaged
parasite dilution factors (three to five mice per group). Dilu-
tion factors for individual mice are also shown: , L. major
lack/; , L. major lack/; , L. major
lack	/. Similar data (not depicted) were obtained for
L. major lack/.
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BALB/c mice to L. major (2, 3), we next analyzed the early
T cell response after infection with the various promasti-
gotes to assess whether LACK deficiency was attenuating
virulence by failure to activate LACK-specific CD4 T cells.
Our previous analysis determined that the period 96 h after
infection corresponded with maximal LACK-reactive T
cell expansion in the draining lymph nodes (6). As assessed
using LACK peptide/I-Ad MHC class II tetramers, how-
ever, no differences were apparent in the expansion of
LACK-reactive T cells in the early response to these vari-
ous lack mutants (Fig. 5).
Next, we used infection of T cell–deficient (TCR-C–
deficient) BALB/c mice to investigate whether the attenu-
ated phenotype of the single copy mutants was indepen-
dent of the adaptive T cell immune response. Although
lesion development was slowed, even using lack/
parasites, consistent with previous observations of experi-
mental leishmaniasis using T cell–deficient animals (38, 39),
single copy lack parasites continued to demonstrate a highly
attenuated disease phenotype (Fig. 4 B). Comparable data
were obtained after inoculation of RAG-2–deficient
BALB/c mice that are deficient in both T and B cells (Fig.
4 C). Analysis of parasite burdens in the infected RAG-
2–deficient mice showed substantial diminution in the
recovery of lack/ parasites as compared with
lack/ parasites (Fig. 4 F). Thus, as assessed both by
lesion size and parasite recovery, lack single copy mutants
display a marked deficiency in the capacity to cause pro-
gressive infection in vivo, even in highly immunodeficient
animals on a genetically susceptible background.
Growth in Macrophages and at Elevated Temperature In Vitro.
The finding that single copy lack parasites displayed impaired
virulence suggested that LACK might be required for effi-
cient growth in macrophages, the major target cell for para-
sitization. To address this issue, bone marrow–derived mac-
rophages were prepared and incubated with the various
mutant parasites for 16 h. After washing, the numbers of in-
fected macrophages were similar in comparing the various
mutant strains, suggesting that the lack mutations do not af-
fect initial entry into macrophages (Fig. 6 A). After 96 h,
however, the percentage of infected macrophages, particu-
larly of macrophages containing large numbers of organisms,
was reduced using single copy lack parasites, and this was
partially overcome using the reconstituted lack	/– para-
sites (Fig. 6 B). Microscopically counting the numbers of
amastigotes present in macrophages after 96 h of in vitro
Figure 5. Analysis of the LACK-specific CD4 T cell response to lack-
targeted L. major. 2 
 106 wild-type or lack-targeted parasites were inoculated
into the hind footpads of BALB/c mice. After 96 h, lymphocytes from
the draining popliteal lymph nodes were assayed for expansion of LACK-
specific CD4 T cells using MHC class II I-Ad/LACK peptide tetramers as
previously described (reference 6). Bars, mean frequencies (two to four
mice) of LACK-specific cells in popliteal lymph nodes for the designated
parasite strains; , individual mice.
Figure 6. Infection of mouse macrophages with lack-targeted L. major
in vitro. BALB/c bone marrow–derived macrophages were incubated
with indicated lack-targeted L. major promastigotes using three parasites
per macrophage. After 16 h at 35C, the monolayers were washed to re-
move extracellular parasites and stained immediately (A), or washed and
then incubated for an additional 80 h at 35C and stained (B). Monolayers
were scored for frequency (percent) of macrophages infected with either
five or more amastigotes (5), one to four amastigotes (1–4), or uninfected
(0). In C, mean numbers of intracellular amastigotes per 100 macrophages
are indicated at 16 and 96 h after infection using the indicated organisms.
For each infection, 200 macrophages were analyzed. Data are averages
from two experiments.
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culture confirmed that single copy mutant parasites essen-
tially did not replicate over a period when lack/ or-
ganisms had increased almost fourfold (Fig. 6 C).
The attenuated development of lesions in vivo and the
impaired capacity to infect macrophages in vitro might re-
flect a general inability to adapt to growth at the elevated
temperatures of the vertebrate host. As noted previously,
growth of each of these variant parasites was similar at 27C
in vitro, reaching comparable densities by day 6 (Fig. 7 A).
When raised to 37C in vitro, both lack/ and
lack	/– parasites suffered loss of viability, although or-
ganisms reached a maximum density of 3 
 106 parasites/
ml. Single copy lack/ parasites suffered a greater ini-
tial loss of viability after raising the culture temperature, and
reached maximal densities approximately twofold lower
than double copy organisms (Fig. 7 B). As such, some of the
loss of virulence in single copy lack L. major may reflect im-
paired capacity to grow at elevated temperature.
Discussion
Although the importance of WD repeat proteins has
been demonstrated in a range of physiologic settings, the
functions of these proteins in the context of infectious dis-
eases remain incompletely characterized. The LACK pro-
tein of L. major is the only protozoan WD repeat protein
for which studies suggest a pathogenic role (2, 3, 5). These
studies have implicated an epitope in LACK as the immu-
nodominant focus for the aberrant Th2-mediated suscepti-
bility of BALB/c mice to L. major (2, 3, 5–6). Immune re-
sponses to the LACK antigen have been documented in
human leishmaniasis (40) and experimental studies have
confirmed an immunoprotective role for LACK when used
as a vaccine against L. major (8–10). Despite this interest,
genetic and biochemical information regarding the role of
LACK in the parasite life cycle remains unknown, and thus
provoked this study to create LACK-deficient L. major.
RACK-like proteins are highly conserved in eukaryotes,
including the kinetoplastids, L. major and Trypanosoma brucei
(24). The tandem arrangement of the two lack genes char-
acterized in this study parallels that found for the two L. in-
fantum lack genes, Li36-1 and Li36-2 (23). Similarly, the
free-living trypanosomatid, C. fasciculata, contains two cop-
ies of a rack homologue, cack (24). The reiterated occur-
rence of these tandemly paired WD repeat genes might be
functionally important in trypanosomatid protozoa. Se-
quencing of the two L. major lack genes, designated lack1
and lack2, revealed predicted proteins that were identical.
Tandem duplications of homologous genes are common
in Leishmania and may represent a mechanism that ensures
coordinated production of sufficient protein levels required
through the parasite life cycle (41, 42). Indeed, our L. major
mutants that lacked one intact, two copy lack allele, were
severely attenuated in the mammalian stage of their life cy-
cle. Despite the ability to target and select individual lack
genes on each allele, lack-null parasites were never isolated,
suggesting, although not formally proving, that LACK is
required for parasite viability. A single haploid gene copy,
either lack1 or lack2, was sufficient to generate parasites that
grew comparably to wild-type L. major promastigotes in
vitro, including the capacity to modify surface carbohy-
drates during stationary phase growth. Despite the require-
ments for these modifications, termed metacyclogenesis, in
establishing intracellular infection, single copy lack1 or lack2
parasites remained essentially avirulent, even when intro-
duced into highly immunodeficient mice, a finding that
correlated with attenuated growth and replication as intra-
cellular amastigotes in macrophages in vitro.
The comparable phenotype of single copy lack1 and
lack2 parasites, together with the effective rescue of single
copy lack1 parasites by replacement of the lack2 coding re-
gion in cis with an XhoI-tagged lack coding region, sug-
gests that threshold levels of LACK are required in amasti-
gotes and such thresholds require coordinate regulation
across both genes on an allele. The regions flanking the
identical lack1 and lack2 coding sequences diverge, suggest-
ing divergent mechanisms for regulating the respective pro-
teins. The inability of single copy lack parasites to thrive in
the intracellular habitat may reflect limitations on LACK
protein thresholds required to establish parasitism or dis-
ruption of regulatory regions responsive to the phagolyso-
somal environment. In either case, the identical nature of
the coding sequences suggests that the defect lies in the lev-
els or regulation of LACK protein, rather than in any qual-
Figure 7. Proliferation of lack-targeted promastigotes at 27 and 37C.
lack-targeted promastigotes of the indicated genotypes were cultured at either
27 or 37C and monitored for proliferation as indicated. Data represent
averages from two experiments.
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itative differences in the lack1 or lack2 gene products. The
lack1 and lack2 transcripts, as well as LACK protein, were
expressed at comparable levels in L. major promastigotes
and amastigotes (1 and unpublished data), and LACK pro-
tein levels, although not absent, were consistently reduced
in the single copy mutants (Fig. 2 A). In contrast to studies
with L. infantum and the related kinetoplastid, C. fasciculata,
where this WD protein was found to associate to distinct
subcellular domains (23, 24), fluorescent imaging of L. ma-
jor promastigotes expressing a GFP-LACK fusion protein
(Fig. 2 B) demonstrated LACK throughout the parasite cy-
tosol. Such generalized cytosolic localization leaves open
the possibility that LACK might be involved in a range of
physiologic pathways in L. major.
Studies examining the potential role of LACK as a can-
didate vaccine antigen for leishmaniasis have documented
important functions for not only CD4 T cells, but also for
CD8 T cells for sustained immunity (10, 43). Despite the
wealth of data demonstrating that LACK is a dominant tar-
get of the immune response during infection, the single
copy lack parasites were highly attenuated in the complete
absence of an adaptive immune response. The phenotype
of L. major lack/ is similar, at least in part, to the
phenotype of lpg2-deficient L. major (44). These mutant L.
major fail to persist in sandflies and macrophages, and cause
minimal disease when inoculated into mice, but can be re-
covered in low numbers months after infection, even from
asymptomatic mice. Such findings suggest that parasite per-
sistence and pathogenesis are separable events and may re-
flect residence of parasites in other host cell types, such as
fibroblasts (45), in addition to macrophages. Such attenu-
ated organisms may not only provide insights into the
mechanisms of parasite persistence, but may have potential
for the development of live Leishmania vaccines.
The loss of virulence upon partial loss of LACK protein
suggests that drugs capable of impeding the activity of
LACK might be highly efficacious in treating leishmania-
sis, even if effects on LACK function are incomplete. Fur-
ther studies of the biochemical pathways affected by
LACK will be necessary to delineate fully the role of this
protein in Leishmania and other kinetoplastids, but, as
confirmed by the genetic studies here, justify the interest
in this family of WD repeat proteins as potential targets for
therapeutic intervention.
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